Dietary Nitrate Acutely and Markedly Increased Exhaled Nitric Oxide in a Cystic Fibrosis Case by Kerley, Conor et al.
Technological University Dublin 
ARROW@TU Dublin 
Articles School of Biological Sciences 
2016-12 
Dietary Nitrate Acutely and Markedly Increased Exhaled Nitric 
Oxide in a Cystic Fibrosis Case 
Conor Kerley 
Technological University Dublin, conor.kerley@gmail.com 
Emma Kilbride 
Peter Greally 
Basil Elnazir 
Follow this and additional works at: https://arrow.tudublin.ie/scschbioart 
 Part of the Medical Immunology Commons 
Recommended Citation 
Kerley CP, Kilbride E, Greally P, Elnazir B. (2016) Dietary Nitrate Acutely and Markedly Increased Exhaled 
Nitric Oxide in a Cystic Fibrosis Case. Clinical medicine and research, 2016 Dec;14(3-4):151-155. doi: 
10.3121/cmr.2016.1320. Epub 2016 Sep 14. 
This Article is brought to you for free and open access by 
the School of Biological Sciences at ARROW@TU Dublin. 
It has been accepted for inclusion in Articles by an 
authorized administrator of ARROW@TU Dublin. For more 
information, please contact 
yvonne.desmond@tudublin.ie, arrow.admin@tudublin.ie, 
brian.widdis@tudublin.ie. 
This work is licensed under a Creative Commons 
Attribution-Noncommercial-Share Alike 3.0 License 
Case Report 
Copyright ©2016 Marshfield Clinic Health System 
Dietary Nitrate Acutely and Markedly Increased 
Exhaled Nitric Oxide in a Cystic Fibrosis Case 
 
Conor P. Kerley, BSc; Emma Kilbride, BSc; Peter Greally, MD; and Basil Elnazir, MD 
 
 
 
 
 
 
 
 
Running title: Dietary nitrate increases exhaled nitric oxide  
 
 
Tables: 3 
Figures: 1 
Abstract word count: 88 
Main text word count: 1,129 
 
 
Insitution at which the work was performed: Paediatric Respiratory Deparment, National 
Children's Hospital, Dublin 24, Ireland. 
 
 
Conflicts of interest: none 
 
 
 
 
 
 
 
 
 
Corresponding Author: 
Conor P. Kerley, BSc     Received: March 16, 2016 
Paediatric Respiratory Department   Revised: August 2, 2016 
National Children's Hospital    Accepted: September 6, 2016 
Tallaght, Dublin 24 
IRELAND      doi:10.3121/cmr.2016.1320 
Email: conorkerley@gmail.com 
 
Financial support: Financial support for this project was provided by the Foundation of National 
Children’s Hospital. The sponsor had no involvement in study design, date collection, analysis or 
interpretation, or manuscript preparation. 
 
 . Published online ahead of print September 14, 2016 as doi:10.3121/cmr.2016.1320Rapid ReleaseCM&R 
 Copyright 2016 by Marshfield Clinic.
Kerley et al.   doi:10.3121/cmr.2016.1320 
Dietary nitrate increases exhaled nitric oxide   Page 2 
Copyright ©2016 Marshfield Clinic Health System 
Abstract 
Airway nitric oxide (NO) is a ubiquitous signaling molecule with bronchoprotective, anti-
inflammatory and anti-infective roles. Cystic fibrosis (CF) is a chronic lung condition associated 
with deceased exhaled NO. Strategies to increase exhaled NO in CF have yielded inconsistent 
results. A potential new method of increasing systemic NO involves ingestion of dietary, 
inorganic nitrate which is reduced to nitrite and NO. We present the case of a 12 year-old, 
athletic male with CF who demonstrated acute but marked increases in exhaled NO following 
dietary nitrate consumption compared to placebo.   
 
Keywords: Cystic fibrosis; Dietary nitrate; Nitrite; Exhaled nitric oxide 
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Introduction 
Nitric oxide (NO) is a ubiquitous signaling molecule with multiple systemic and airway roles. 
Cystic fibrosis (CF) is a chronic lung condition which is associated with decreased fraction of 
exhaled NO (FeNO)1-4. 
 
The impact of decreased FeNO in CF is unclear. However, potentially of relevance to CF, NO 
has bronchoprotective, anti-inflammatory and anti-infective roles as well as effects on ion 
transport5 and ciliary motility6. Interestingly, pulmonary function in CF subjects is positively 
correlated to airway NO7 and sputum NO metabolites8. Further, NO deficiency contributes to 
impairment of airway relaxation in a murine model of CF1. Therefore, increasing NO levels may 
be of functional importance in CF. Strategies to increase FeNO in CF have included inhaled NO, 
L-arginine and PDE5 inhibitors (e.g. sildenafil ®) but have yielded inconsistent safety and 
efficacy profiles (table 3). 
 
Until recently, it was thought that the only pathway for NO synthesis in vivo was via oxidation of 
L-arginine in the presence of oxygen catalysed by NO synthase (NOS) enzymes. However 
recently an alternative pathway for in vivo NO synthesis has been discovered whereby inorganic 
nitrate is reduced by oral bacteria to nitrite. This nitrite can be further reduced to NO 
enzymatically and non-enzymatically9. Dietary nitrate is now recognized as an additional and 
very significant source of NO, whereby a single serving of a nitrate rich vegetables (e.g. spinach) 
contains more nitrate than what is endogenously formed by the all three NOS isoforms combined 
in 24h9. Recent human intervention trials have demonstrated hypotensive and ergonomic effects 
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of dietary nitrate in conjunction with increased blood NO metabolites among multiple healthy 
and clinical groups.  
 
Case report 
We present a 12 year-old, non-smoking, athletic, male (BMI = 19 kg/m2) with CF, normal lung 
function (FEV1 = 105%) and pancreatic sufficiency. This case initially presented early in life 
with a history of recurrent chest infections and wheezy episodes. An initial sweat test chloride of 
112 and confirmatory sweat test chloride of 106 in addition to genotype analysis 
(F508/c.262_263delTT) lead to a CF diagnosis at 9 months of age. Current investigations 
revealed a normal x-ray, DEXA, and glucose tolerance test with no recent hospital admissions or 
gastrointestinal symptoms. Further, the case had no other medical history of note, including no 
asthma or allergy (which could influence FeNO measurement). He generally requires antibiotics 
every 8-12 weeks but had no recent infection or antibiotic use and had no evidence of concurrent 
bacterial colonization. Further his medication regimen was stable and typical for a CF case (table 
1). We utilized a double-blind, randomized, placebo-controlled, crossover design to assess the 
acute impact of dietary nitrate as 140ml beetroot juice (BRJ, 12.9mmol nitrate) or 140ml 
matched, nitrate-depleted beetroot juice (PL, <0.5mmol) on exhaled NO. This nitrate dose is 
obtainable with a diet rich in vegetables.  
 
We conducted two clinic visits 14 days apart, where there were no relevant changes in factors 
known to influence NO (including diet, exercise and medication habits). On the morning of each 
study visit, the subject did not use any medications or complete chest physio and consumed an 
identical, low nitrate breakfast which was confirmed by a review with a dietitian (CPK). On both 
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days, in an identical manner and at the same time, FeNO (NiOx MINO; Aerocrine, Sweden) and 
pulmonary function were assessed before and 1.5h after the study beverage. We added water and 
blackcurrant cordial (sugar- and nitrate-free) to the juice in an identical manner on both days to 
make it more palatable at the request of the subject. The 1.5h delay between baseline and post-
beverage testing was to facilitate in-vivo reduction of dietary nitrate to NO9. During this delay, 
the case rested quietly in a clinic room and did not exercise, eat, drink or take medication. This 
case report intervention complies with the Declaration of Helsinki and approval was granted by 
the research ethics committee of The National Children’s Hospital. Written informed consent 
was provided by the mother for permission to conduct and publish this case report.  
 
There was no effect on pulmonary function after either beverage. However, 1.5h following BRJ, 
FeNO increased by 150% (30ppb) but decreased by 17% after PL (-4ppb) (figure 1 and table 2).  
 
Discussion 
To our knowledge, this is the first report of dietary nitrate in CF. The acute but marked FeNO 
incease following dietary nitrate compares favourably to other NO therapies in CF (table 3). 
Interestingly, the subject studied here did not have low baseline FeNO (20ppb). Dietary nitrate as 
a precursor to NO seems most effective in those with dysregulated NO and therefore it is 
possible that dietary nitrate may increase FeNO to a similar or greater extent in those with 
diminished baseline FeNO. Despite an increase in FeNO, there was no effect on lung functon. In 
this context, it is noteworthy that baseline lung function was not impaired (105%), perhaps 
minimising any potential benefit.  
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Dietary nitrate is water soluble and rapidly absorbed ~100% in the stomach and small intestine. 
There is no evidence of nitrate malabsorption in CF. Approximately 75% of ingested nitrate is 
excreted via the kidneys with the remainder concentrated in the oral gland and subsequently 
reduced to nitrite by tongue anaerobes. This nitrite is swallowed and then further reduced to NO 
under suitable conditions within the airway, stomach and endothelium. After nitrate ingestion, 
salivary/plasma nitrate levels increase rapidly (~15m) and peaking at 90-120m13. The levels 
remain high for several hours following ingestion after which they slowly decline, remaining 
elevated from baseline for ~24h13. This is why we measured FeNO before and 1.5h after each of 
2 beverages. Further, we measured total exhaled NO. Future studies may utilize different doses 
of nitrate among larger groups as well employ serial measurements of NO, nitrate and nitrite to 
further our understanding of NO metabolism in response to exogenous nitrate in CF. 
Importantly, this CF case did not display several behaviors known to decrease the reduction of 
dietary nitrate to NO including use of tobacco14 antibiotics15 or mouthwash16. 
 
Although, our report is limited to a single male, CF case with mild disease, dietary nitrate is a 
component of certain vegetables, appears remarkably safe and increased FeNO to a greater 
extent than exisitng CF therapies.  
 
Nitrate and nitrate, as precursors to NO, are known to have broad antimicrobial effects10-12, 
including against common pathogens in CF such as Pseudomonas aeruginosa10, 12 and 
Staphylococcus aureus12. Further, this antimicrobial activity has been demonstrated under cystic 
fibrosis airway conditions10.  
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We recommend that future studies measuring FeNO are aware of potential confounding by 
dietary intake. Further the dietetic focus regarding CF typically emphasizes dietary fat with little 
focus on vegetable intake. We suggest the dietary modification of FeNO, including via vegetable 
consumption in CF is worthy of further exploration. We suggest the dietary modification of 
FeNO, including via vegetable consumption in CF is worthy of further exploration.  
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Table 1: Current medication regimen 
 
Bronchodilators Ventolin 
Flixotide 
PERT Creon 
Airway clearence aid Nebulized pulmozyme 
Nutritional supplements Vitamin D 
Aquadex 
Probiotics 
Chest physio Twice daily with acapella® device. 
PERT = pancreatic enzyme repalcement therapy. 
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Table 2: Pulmonary function tests 
 
 Day 1 Day 2 
Intervention BRJ PL 
Baseline   
FeNO (ppb) 20 24 
FVC L (%) 3.66 (106) 3.63 (105) 
FEV1 L (%) 3.07 (107) 3.03 (105) 
Post beverage   
FeNO (ppb) 50 20 
FVC L (%) 3.67 (106) 3.52 (101) 
FEV1 L (%) 3.06 (106) 2.9 (101) 
Abbreviations:  
BRJ = nitrate-rich neetroot juice; FeNO = fraction exhaled nitric oxide;  FEV1 = forced expiratory volume; FVC = 
forced vital capacity; ppb = parts per billion; PL = placebo - nitrate-depleted beetroot juice.  
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Figure 1: FeNO response to BRJ and PL 
 Abbeviations:  BRJ = nitrate-rich; PL = placebo, nitrate-depleted beetroot juice.  
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